Catherine E Willett

Phylonix Pharmaceuticals, Inc.

$2,861,955

Attributed

$2,861,955

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding mix

By agency

NIH$2,861,955 · 10

By mechanism

R43$1,468,774 · 8

R44$1,393,181 · 2

Top collaborators

No co-investigators on record.

Most similar at Phylonix Pharmaceuticals, Inc.

Same institution · by research overlap

Wen L Seng$5,142,092
George N Serbedzija$822,432
Demian Park$957,438
Chuenlei Parng$2,901,526

Others in their field

Top investigators on “Zebrafish”

Leonard I Zon · Children'S Hospital Boston$58,820,730
Monte Westerfield · University Of Oregon$50,217,878
Richard A Gibbs · Baylor College Of Medicine$49,965,365
Karl Alexander Deisseroth · Stanford University$29,745,200
William S Talbot · Stanford University$29,496,829
Robert L Tanguay · Oregon State University$27,361,484

Research focus

ZebrafishDrug Screening /EvaluationModel Design /DevelopmentGene ExpressionEmbryo /Fetus ToxicologySubtraction HybridizationDisease /Disorder ModelMicroarray TechnologyPharmacokineticsNucleic Acid SequenceTechnology /Technique DevelopmentMethod DevelopmentDrug Adverse EffectDna DamageCytotoxicityAlternatives To Animals In ResearchNorthern BlottingsCell TransplantationAngiogenesisPharmacogeneticsHigh Throughput TechnologyBiomarkerEmbryo /Fetus CultureEmbryogenesis